104 related articles for article (PubMed ID: 8135775)
21. Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies.
Akamizu T; Kohn LD; Hiratani H; Saijo M; Tahara K; Nakao K
J Clin Endocrinol Metab; 2000 Jun; 85(6):2116-21. PubMed ID: 10852437
[TBL] [Abstract][Full Text] [Related]
22. Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor.
Minich WB; Lenzner C; Morgenthaler NG
Clin Exp Immunol; 2004 Apr; 136(1):129-36. PubMed ID: 15030524
[TBL] [Abstract][Full Text] [Related]
23. The occurrence of thyrotropin binding-inhibiting immunoglobulins and thyroid-stimulating antibodies in patients with silent thyroiditis.
Morita T; Tamai H; Oshima A; Mukuta T; Fukata S; Kuma K; Kumagai LF; Nagataki S
J Clin Endocrinol Metab; 1990 Oct; 71(4):1051-5. PubMed ID: 1976125
[TBL] [Abstract][Full Text] [Related]
24. Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: its incidence and characteristics of action.
Arikawa K; Ichikawa Y; Yoshida T; Shinozawa T; Homma M; Momotani N; Ito K
J Clin Endocrinol Metab; 1985 May; 60(5):953-9. PubMed ID: 2858492
[TBL] [Abstract][Full Text] [Related]
25. Role of blocking TSH receptor antibodies on the development of hypothyroidism and thyroid atrophy in primary myxedema.
Cho BY; Shong YK; Lee HK; Koh CS; Min HK; Sohn I
Korean J Intern Med; 1989 Jul; 4(2):108-17. PubMed ID: 2577255
[TBL] [Abstract][Full Text] [Related]
26. Possible binding site of thyrotropin binding inhibitor immunoglobulin (TBII) on the thyrotropin (TSH) receptor, which is different from TSH binding site.
Piraphatdist T; Sugawa H; Inoue D; Enomoto T; Mori T; Imura H
Biochem Biophys Res Commun; 1990 Oct; 172(2):529-36. PubMed ID: 1978673
[TBL] [Abstract][Full Text] [Related]
27. Dissociation between iodide-induced thyroiditis and antibody-mediated hyperthyroidism in NOD.H-2h4 mice.
McLachlan SM; Braley-Mullen H; Chen CR; Aliesky H; Pichurin PN; Rapoport B
Endocrinology; 2005 Jan; 146(1):294-300. PubMed ID: 15459116
[TBL] [Abstract][Full Text] [Related]
28. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T
Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957
[TBL] [Abstract][Full Text] [Related]
29. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
Lenzner C; Morgenthaler NG
Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
[TBL] [Abstract][Full Text] [Related]
30. Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.
Brokken LJ; Wiersinga WM; Prummel MF
J Clin Endocrinol Metab; 2003 Sep; 88(9):4135-8. PubMed ID: 12970276
[TBL] [Abstract][Full Text] [Related]
31. Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.
Baker G; Mazziotti G; von Ruhland C; Ludgate M
Endocrinology; 2005 Feb; 146(2):835-44. PubMed ID: 15542454
[TBL] [Abstract][Full Text] [Related]
32. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
[TBL] [Abstract][Full Text] [Related]
33. Differences between thyrotropin receptor antibody bioactivity and inhibition of 125I-bovine thyrotropin binding.
Wallaschofski H; Kaczmarek M; Miehle K; Hentschel B; Paschke R
Thyroid; 2000 Oct; 10(10):897-907. PubMed ID: 11081256
[TBL] [Abstract][Full Text] [Related]
34. Comparison of atrophic and goitrous auto-immune thyroiditis in children: clinical, laboratory and TSH-receptor antibody studies.
Matsuura N; Konishi J; Yuri K; Harada S; Fujieda K; Nohara Y; Mikami Y; Kasagi K; Iida Y; Hosoda A
Eur J Pediatr; 1990 May; 149(8):529-33. PubMed ID: 2347350
[TBL] [Abstract][Full Text] [Related]
35. Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins.
Takasu N; Yamada T; Katakura M; Yamauchi K; Shimizu Y; Ishizuki Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):239-45. PubMed ID: 2878935
[TBL] [Abstract][Full Text] [Related]
36. Goitrous hypothyroidism with blocking or stimulating thyrotropin binding inhibitor immunoglobulins.
Sato K; Okamura K; Yoshinari M; Ikenoue H; Kuroda T; Torisu M; Fujishima M
J Clin Endocrinol Metab; 1990 Oct; 71(4):855-60. PubMed ID: 1976127
[TBL] [Abstract][Full Text] [Related]
37. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
[TBL] [Abstract][Full Text] [Related]
38. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
39. A coated tube assay for the detection of blocking thyrotropin receptor autoantibodies.
Minich WB; Lenzner C; Bergmann A; Morgenthaler NG
J Clin Endocrinol Metab; 2004 Jan; 89(1):352-6. PubMed ID: 14715871
[TBL] [Abstract][Full Text] [Related]
40. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
